Embolic agents used for bronchial artery embolisation in massive haemoptysis

Bibliography

• JOHNSON JL: Manifestations of hemoptysis. Postgrad. Med. (2002) 112:101–108.
   PubMed Web of Science ®Google Scholar
• YOON W, KIM JK, KIM YH,CHUNG TW, KANG HK: Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review.RadioGraphics (2002) 22:1395–1409.
   PubMed Web of Science ®Google Scholar
• •A review of the overall aspects of both massive haemoptysis and bronchial artery embolisation.
   Google Scholar
• MAURO MA, JAQUES PF: Transcatheter bronchial artery embolization for inflammation (hemoptysis). In: Abrams' angiography interventional radiologyBaum S, Pentecost MJ (Eds), Little Brown and Company, Philadelphia, USA (1997):819–828.
   Google Scholar
• JEAN-BAPTISTE E: Clinical assessment and management of massive hemoptysis. Crit. Care Med. (2000) 28:1642–1647.
   PubMed Web of Science ®Google Scholar
• CONLAN AA, HURWITZ SS, KRIGE Let al.: Massive hemoptysis: review of 123 cases.' Thorac. Cariovasc. Sorg. (1983) 85:120–124.
   Google Scholar
• KNOTT-CRAIG CJ, OOSTUIZEN JG, ROSSOUW G, JOUBERT JR, BARNARD PM: Management and prognosis of massive hemoptysis. Recent experience with 120 patients. I Thorac. Cardiovasc. Surg. (1993) 105:394–397.
   Google Scholar
• REVEL MP, FOURNIER LS,HENNEBI CUE AS et al.: Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? Jim. .1 Roentgenol. (2002) 179:1217–1224.
   Google Scholar
• LORDON JL, GASCOIGNE A, CORRIS PA: The pulmonary physician in critical care Illustrative case 7: assessment and management of massive haemoptysis. Thorax (2003) 58:814–819.
   PubMedGoogle Scholar
• •A good review of conservative and bronchoscopic treatment in patients with massive haemoptysis.
   Google Scholar
• JOUGON J, BALLESTER M,DELCAMBRE F et al.: Massive hemoptysis: what place for medical andsurgical treatment. Ear: Cardiothorac. Sing. (2002) 22:345–351.
   Google Scholar
• REMY J, VOISIN C, RIBET M et al: Treatment, by embolization, of severe or repeated hemoptysis associated with systemic hypervascularization. Nouv. Presse Med. (1973) 2:2060-2068 [French].
   Google Scholar
• GOH PYT, LIN M, TEO N, WONG DE: Embolization for hemoptysis: a six-year review. Cardiovasc. Inter vent. Radial. (2002) 25:17–25.
   PubMedGoogle Scholar
• WONG ML, SZKUP P, HOPLEY MJ: Percutaneous embolotherapy for life-threatening hemoptysis. Chest (2002) 121:95–102.
   PubMed Web of Science ®Google Scholar
• SWANSON KL, JOHNSON CM, PRAKASH UBS et al.: Bronchial artery embolization: experience with 54 patients. Chest (2002) 121:789–795.
   PubMed Web of Science ®Google Scholar
• FERNANDO HC, STEIN M, BENFIELD JR, LINK DP: Role of bronchial artery embolization in the management of hemoptysis. Arch. Surg. (1998) 133:862–866.
   PubMedGoogle Scholar
• YOON W, KIM YH, KIM JK et a/.: Massive hemoptysis: prediction of nonbronchial systemic arterial supply with chest CT. Radiology (2003) 227:232–238.
   Google Scholar
• ENDO S, OTANI S, SAITO N et al: Management of massive hemoptysis in a thoracic surgical unit. Ear. Cardiothorac. Surg. (2003) 23:467–472.
   PubMedGoogle Scholar
• TADAVARTHY SM, MOLLER JH, AMPLATZ K: Polyvinyl alcohol (Ivalon): a new embolic material. Am. J. Roentgenol (1975) 125:609–616.
   Google Scholar
• GRINDLAY JH, CLAGGETT OT: Plastic sponge prosthesis for use after pneumonectomy: preliminary report. Proc. Mayo Clin. (1949) 24:1538–1539.
   Google Scholar
• DERDEYN CP, MORAN CJ, CROSS DT, DIETRICH HH, DACEY RG: Polyvinyl alcohol particle size and suspension characteristics. AINR Am. J. Neuroradiol (1995) 16:1335–1343.
   PubMed Web of Science ®Google Scholar
• ••A study evaluating the size and shapecharacteristics of commercially available PVA particles.
   Google Scholar
• MORAN CJ, CROSS DT,DERDEYN CP: Neurointerventional materials. Semin. Interv. Radial. (2002) 19:289–311.
   Google Scholar
• TADAVARTHY SM, KNIGHT L,OVITT TW, SNYDER C, AMPLATZ K: Therapeutic transcatheter arterial embolization. Radiology (1974) 111:13–16.
   Google Scholar
• KATOH 0, KISHIKAWA T, YAMADA H, MATSUMOTO S, KUDO S: Recurrent bleeding after arterial embolization in patients with hemoptysis. Chest (1990) 97:541–546.
   PubMed Web of Science ®Google Scholar
• COHEN AM, DOERSHUK CE STERN R: Bronchial artery embolization to control hemoptysis in cystic fibrosis. Radiology (1990) 175:401–405.
   PubMedGoogle Scholar
• TONKIN ILD, HANISSIAN AS, BOULDEN TF et al.: Bronchial arteriography and embolotherapy for hemoptysis in patients with cystic fibrosis. Cardiovasc. Intervent. Radial. (1991) 14:241–246.
   PubMedGoogle Scholar
• TOMASHEFSKI JF, COHEN AM, DOERSHUK CF: Longterm histopathologic follow-up of bronchial arteries after therapeutic embolization with polyvinyl alcohol (Ivalon) in patients with cystic fibrosis. Human Pathol (1988) 19:555–561.
   PubMedGoogle Scholar
• •A study showing histopathological changes after embolisation of human bronchial artery with PVA particles.
   Google Scholar
• PUMP K: Distribution of bronchial arteriesin human lung. Chest (1972) 62:447–451.
   PubMedGoogle Scholar
• TOBIN CE: The bronchial arteries and their connections with other vessels in the human lung. Surg. Cynecol Obstet. (1952) 95:741–750.
   PubMedGoogle Scholar
• PELAGE JP, LAURENT A, WASSEF M et al.: Uterine artery embolization in sheep: comparison of acute effects with polyvinyl alcohol particles and calibrated microspheres. Radiology (2002) 224:436–445.
   PubMed Web of Science ®Google Scholar
• •A recent experimental study showing many differences between PVA particles and embospheres.
   Google Scholar
• CHOE DH, HAN MH, KANG GH, YEON KM, HAN MC: An experimental study of embolic effect according to infusion rate and concentration of suspension in transarterial particulate embolization. Invest. Radial. (1997) 32:260–267.
   PubMed Web of Science ®Google Scholar
• •A study showing that both infusion rate and concentration of PVA suspension greatly influence on the level of arterial occlusion.
   Google Scholar
• BARR JD, LEMLEY TJ,PETROCHKO CN: Polyvinyl alcohol foam particle sizes and concentrations injectable through microcatheters." Vasc. Interv. Radial. (1998) 9:113–118.
   PubMedGoogle Scholar
• GERMANO IM, DAVIS RL,WILSON CB, HIESHIMA GB: Histopathological follow-up study of 66 cerebral arteriovenous malformations after therapeutic embolization with polyvinyl alcohol.j Neurosurg. (1992) 76:607–614.
   PubMed Web of Science ®Google Scholar
• ••Study defining various histopathologicalchanges after embolisation with PVA.
   Google Scholar
• JACK CR, FORBES G, DEWANJEE MK, BROWN ML, EARNEST F: Polyvinyl alcohol sponge for embolotherapy: particle size and morphology. AINR Am. .1. Neuroradiol (1985) 6:595–597.
   PubMed Web of Science ®Google Scholar
• REPA I, MORADIAN GP, DEHNER LP et al.: Mortality associated with use of a commercial suspension of polyvinyl alcohol. Radiology (1989) 170:395–399.
   PubMed Web of Science ®Google Scholar
• DAVIDSON GS, TERBRUGGE KG: Histologic long-term follow-up after embolization with polyvinyl alcohol particles. AINR Am. J. Neuroradiol (1995) 16:843–846.
   PubMedGoogle Scholar
• WHITE R, STRANBERG JV, GROSS G, BARTH K: Therapeutic embolization with long-term occluding agents and their effects on embolized tissues. Radiology (1977) 125:677–687.
   PubMed Web of Science ®Google Scholar
• CREMASHI P, NASIMBENE C, VITULO P et al: Therapuetic embolizationof the bronchial artery: a successful treatment in 209 cases of relapse hemoptysis. Angiology (1993) 44:295–299.
   PubMedGoogle Scholar
• KATO A, KUDO S, MATSUMOTO K et al.: Bronchial artery embolization for hemoptysis due to benign diseases: immediate and long-term results. Cardiovasc. Intervent. Radial. (2000) 23:351–357.
   PubMedGoogle Scholar
• BARBEN J, ROBERTSON D,OLINSKY A, DITCHFIELD M: Bronchial artery embolization for hemoptysis in young patients with cystic fibrosis. Radiology (2002) 224:124–130.
   PubMedGoogle Scholar
• BERENSTEIN A, RUSSEL E: Gelatin sponge in therapeutic neuroradiology: a subject review. Radiology (1981) 141:105–112.
   PubMed Web of Science ®Google Scholar
• SPEAKMAN TJ: Internal occlusion of a carotid-cavernous fistula. J. Neurosurg. (1964) 21:303–305.
   PubMedGoogle Scholar
• BARTH KH, STRANDBERG JD, WHITE RI: Long-term follow-up of transcatheter embolization with autologous clot, oxycel, and Gelfoam in domestic swine. Invest. Radial. (1977) 12:273–280.
   PubMedGoogle Scholar
• SISKIN GP, ENGLANDER M,STAINKEN BF et al.: Embolic agents used for uterine fibroid embolization. Am. J. Roentgenol (2000) 175:767–773.
   Google Scholar
• UFLACKER R, KAEMMERER A, PICON PD et al.: Bronchial artery embolization in the management of hemoptysis: technical aspects and long-term results. Radiology (1985) 157:637–644.
   PubMed Web of Science ®Google Scholar
• HAYAKAWA K, TANAKA F,TORIZUKA T et al.: Bronchial artery embolization for hemoptysis: immediate and long-term results. Cardiovasc. Intervent. Radial. (1992) 15:154–159.
   Google Scholar
• RAMAKANTAN R, BANDEKAR VG, GANDHI MS, AULAKH BG, DESHMUKH HL: Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization.Radiology (1996) 200:691–694.
   PubMedGoogle Scholar
• TANAKA N, YAMAKADO K, MURASHIMA S et al.: Superselective bronchial artery embolization for hemoptysis with a coaxial microcatheter system. J. Vasc. Interv. Radial. (1997) 8:65–70.
   PubMedGoogle Scholar
• CHAPMAN SA, HOLMES MD, TAYLOR DJ: Unilateral diaphragmatic paralysis following bronchial artery embolization. Chest (2001) 118:269-270.366
   Google Scholar
• LAURENT A, BEAUJEUX R, WASSEF M et al.: Trisacryl gelatin microspheres for therapeutic embolization,I: development and M vitro evaluation. AMR Am. Neuroradiol (1996) 17:533–540.
   PubMed Web of Science ®Google Scholar
• BEAUJEUX R, LAURENT A, WASSEF M et al.: Trisacryl gelatin microspheres for therapeutic embolization,II: preliminary clinical evaluation in tumors and arteriovenous malformations. AMR Am. J. Neuroradiol (1996)17:541–548.
   PubMed Web of Science ®Google Scholar
• •The first report of the clinical use of embosphere as an embolic agent.
   Google Scholar
• BENDSZUS M, KLEIN R, BURGER R et al.: Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. AMR Am. I Neuroradiol (2000) 21:255–261.
   PubMed Web of Science ®Google Scholar
• SPIES JB, BENEANATI JF, WORTHINGTON-KIRSCH RL: PELAGE JP: Initial experience with use of tris-acryl gelatin microspheres for uterine artery embolization for leiomyomata. Vase. Interv. Radial. (2001) 12:1059–1063.
   PubMed Web of Science ®Google Scholar
• PELAGE JP, DREF OL, BEREGI JP et al.:Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J. Vase. Interv. Radial. (2003) 14:15–20.
   PubMed Web of Science ®Google Scholar
• DERDEYN CP, GRAVES VB,SALAMAT S, RAPPE A: Collagen-coated acrylic microspheres for embolotherapy: in vivo and in vitro characteristics. AJNR Am. J. Neuroradiol (1997) 18:647–653.
   PubMed Web of Science ®Google Scholar
• ••An experimental study showing theadvantageous characteristics of embospheres compared with PVA.
   Google Scholar
• SISKIN GP, DOWLING K, VIRMANI R, JONES R, TODD D: Pathologic evaluation of a spherical polyvinyl alcohol embolic agent in a porcine renal model.Vase. Interv. Radial. (2003) 14:89–98.
   PubMed Web of Science ®Google Scholar